Cutaneous leishmaniasis: 20 years' experience in a Spanish tertiary care hospital;Leishmaniasis cutánea. Experiencia de 20 años en un hospital español de tercer nivel

Actas Dermo-Sifiliograficas

Volumn 106, Issue 4, 2015, Pages 310-316

  Giavedoni, P ^a   Iranzo, P ^a   Fuertes, I ^a   Estrach, T ^a   Alsina Gibert, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cutaneous; Immunodepressed; Leishmaniasis; Meglumineantimonate

Indexed keywords

MEGLUMINE ANTIMONATE; AMPHOTERICIN B LIPID COMPLEX; LIVER ENZYME; PANCREAS ENZYME; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CLINICAL FEATURE; CONSULTATION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN ULCER; SPAIN; TERTIARY CARE CENTER; WORK EXPERIENCE; ACUTE KIDNEY FAILURE; ADOLESCENT; AGED; HEART SUPRAVENTRICULAR ARRHYTHMIA; MOLECULAR DIAGNOSIS; PERSONAL EXPERIENCE; RETROSPECTIVE STUDY; SIDE EFFECT; AFRICA; COMORBIDITY; ENDEMIC DISEASE; ETHNOLOGY; HIV INFECTIONS; IMMUNOCOMPROMISED PATIENT; LEISHMANIASIS, CUTANEOUS; MIGRANT; SOUTH AND CENTRAL AMERICA; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA, NORTHERN; AGED; ANTIPROTOZOAL AGENTS; COMORBIDITY; EMIGRANTS AND IMMIGRANTS; ENDEMIC DISEASES; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LATIN AMERICA; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; SPAIN; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84929517111     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2014.12.003     Document Type: Article

References (23)

1. P. Desjeux Leishmaniasis: Current situation and new perspectives Comp Immunol Microbiol Infect Dis 27 2004 305 318
2. P.D. Ready Leishmaniasis emergence in Europe Euro Surveill 11 2010 19505
3. B. Suárez Rodríguez, B. Isidoro Fernández, and S. Santos Sanz Review of the current situation and the risk factors of Leishmania infantum in Spain Rev Esp Salud Publica 86 2012 555 564
4. U. González, M. Pinart, L. Reveiz, and J. Alvar Interventions for old world cutaneous leishmaniasis (review) Cochrane Database Syst Rev 8 2008 CD005067
5. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Resultados de la vigilancia epidemiológica de las enfermedades transmisibles. Informe anual 2011. Madrid; 2013.
6. M. Aguado, P. Espinosa, A. Romero-Maté, J.C. Tardío, S. Córdoba, and J. Borbujo Brote de leishmaniasis cutánea en el municipio de Fuenlabrada Actas Dermosifiliogr 104 2013 334 342
7. J. Alvar, I. Vélez, C. Bern, M. Herrero, P. Desjeux, and J. Cano Leishmaniasis worldwide and global estimates of its incidence PLoS One 7 2012 e35671
8. M. Gramiccia, and L. Gradoni The current status of zoonotic leishmaniases and approaches to disease control Int J Parasitol 35 2005 1169 1180
9. R. Reithinger, J.C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker Cutaneous leishmaniasis Lancet Infect Dis 7 2007 581 596
10. A. Masmoudi, W. Hariz, S. Marrekchi, M. Amouri, and H. Turki Old world cutaneous leishmaniasis: Diagnosis and treatment J Dermatol Case Rep 30 2013 31 41
11. J. Van Griensven, E. Carrillo, R. López-Vélez, L. Lynen, and R. Moreno Leishmaniasis in immunosuppressed individuals Clin Microbiol Infect 20 2014 286 299
12. A. Meyerhoff U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis Clin Infect Dis 28 1999 42 48
13. D. García-Almagro Leishmaniasis cutánea Actas Dermosifiliogr 96 2005 1 24
14. A. Pérez-Ayala, F. Norman, J.A. Pérez-Molina, J.M. Herrero, B. Monge, and R. López-Vélez Imported leishmaniasis: A heterogeneous group of diseases J Travel Med 16 2009 395 401
15. A.K. Boggild, A.P. Ramos, D. Espinosa, B.M. Valencia, N. Veland, and C. Miranda-Verastegui Clinical and demographic stratification of test performance: A pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis Am J Trop Med Hyg 83 2010 345 350
16. S. Shirian, A. Oryan, G. Hatam, S. Panahi, and Y. Daneshbod Comparison of conventional, molecular, and immunohistochemical methods in diagnosis of typical and atypical cutaneous leishmaniasis Arch Pathol Lab Med 138 2014 235 240 32
17. I. Estandiarpour, S. Farajzadeh, Z. Rahnama, E. Fathabadi, and A. Herhmatkhan Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis Int J Dermatol 51 2012 1221 1225
18. L.F. Oliveira, A.O. Schubach, M.M. Martins, S.L. Passos, R.V. Oliveira, and M.C. Marzochi Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the new world Acta Trop 118 2011 87 96
19. H. Goto, and J.A. Lauletta-Lindoso Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis Expert Rev Anti Infect Ther 8 2010 419 433
20. M. López-Escobar, M. Drake-Monfort, R. Salesa-Gutiérrez de Rozas, and S. Hermana-Ramírez Leishmaniasis cutánea esporotricoide Actas Dermosifiliogr 98 2007 441 445
21. J. Blum, P. Buffet, L. Visser, G. Harms, M.S. Bailey, and E. Caumes LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014 J Trav Med 21 2014 116 129
22. M. Solomon, S. Baum, A. Barzilai, F. Pavlotsky, H. Trau, and E. Schwartz Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate J Eur Acad Dermatol Venereol 23 2009 1189
23. B. Monge-Maillo, and R. López-Vélez Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis Drugs 73 2013 1889 1920